I agree that this site is using cookies. You can find further informations here.
X
Usmani, SZ
25  results:
OpenAccess-fulltext X
Search for persons X
?
1

Rates of Influenza and Pneumococcal Vaccination and Correla..:

Thompson, MA ; Boccadoro, M ; Leleu, X...
https://eprints.whiterose.ac.uk/195853/6/Rates%20of%20Influenza%20and%20Pneumococcal%20Vaccination%20and%20Correlation%20With%20Survival%20in%20Multiple%20Myeloma%20Patients.pdf.  , 2023
Link: https://eprints.whiteros..
 
?
2

Final analysis of the phase III non-inferiority COLUMBA stu..:

Usmani, SZ ; Nahi, H ; Legiec, W...
Haematologica: the hematology journal, 2022,.  , 2022
Link: https://repository.icr.a..
 
?
3

B05: RESULTS FROM A META-ANALYSIS OF CILTACABTAGENE AUTOLEU..:

Gay, F ; Berdeja, JG ; De Stefano, V...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009793/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

P05: DARATUMUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE VERSUS..:

Dimopoulos, MA ; Oriol, A ; Nahi, H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009798/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
5

B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUM..:

Mateos, M ; Hari, P ; Bahlis, N...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012119/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

Perspectives on the Risk-Stratified Treatment of Multiple M..:

Davies, FE ; Pawlyn, C ; Usmani, SZ...
699310.  , 2022
Link: https://repository.icr.a..
 
?
7

Daratumumab plus lenalidomide and dexamethasone in transpla..:

Facon, T ; Cook, G ; Usmani, SZ...
issn:0887-6924.  , 2022
Link: http://hdl.handle.net/11..
 
?
8

Management of patients with multiple myeloma beyond the cli..:

Terpos, E ; Mikhael, J ; Hajek, R...
Blood cancer journal, 2021, 11 (2), pp. 40 - ?.  , 2021
Link: https://repository.icr.a..
 
?
9

Treatment of relapsed and refractory multiple myeloma: reco..:

Moreau, P ; Kumar, SK ; Miguel, JS...
https://discovery.ucl.ac.uk/id/eprint/10125552/1/IMWG_relapse_V6_AUGUST_8_2020.pdf.  , 2021
Link: https://discovery.ucl.ac..
 
?
10

Management of patients with multiple myeloma beyond the cli..:

Terpos, E ; Mikhael, J ; Hajek, R...
https://eprints.whiterose.ac.uk/171668/6/s41408-021-00432-4.pdf.  , 2021
Link: https://eprints.whiteros..
 
?
11

Ixazomib-lenalidomide-dexamethasone in routine clinical pra..:

Hájek, R ; Minařík, J ; Straub, J...
https://eprints.whiterose.ac.uk/173693/6/fon-2020-1225.pdf.  , 2021
Link: https://eprints.whiteros..
 
?
12

Exposure-Response and Population Pharmacokinetic Analyses o..:

Luo, MM ; Usmani, SZ ; Mateos, M-V...
Journal of clinical pharmacology, 2020.  , 2021
Link: https://repository.icr.a..
 
?
13

Daratumumab, lenalidomide, and dexamethasone in relapsed/re..:

Kaufman, JL ; Dimopoulos, MA ; White, D...
https://eprints.whiterose.ac.uk/168243/1/Kaufman.POLLUX%20Cyto%20Risk.BCJ.2020.pdf.  , 2020
Link: https://eprints.whiteros..
 
?
14

Daratumumab, lenalidomide, and dexamethasone in relapsed/re..:

Kaufman, JL ; Dimopoulos, MA ; White, D...
issn:2044-5385.  , 2020
Link: http://hdl.handle.net/11..
 
?
15

INSIGHT MM: a large, global, prospective, non-interventiona..:

Costello, C ; Davies, FE ; Cook, G...
https://eprints.whiterose.ac.uk/149400/1/fon-2019-0013_FK.pdf.  , 2019
Link: https://eprints.whiteros..
 
1-15